Cargando…
Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke
Inflammation following ischemic brain injury is correlated with adverse outcome. Preclinical studies indicate that treatment with acetylsalicylic acid + extended-release dipyridamole (ASA + ER-DP) has anti-inflammatory and thereby neuroprotective effects by inhibition of monocyte chemotactic protein...
Autores principales: | Worthmann, Hans, Dengler, Reinhard, Schumacher, Helmut, Schwartz, Andreas, Eisert, Wolfgang G., Lichtinghagen, Ralf, Weissenborn, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430258/ https://www.ncbi.nlm.nih.gov/pubmed/22942727 http://dx.doi.org/10.3390/ijms13078670 |
Ejemplares similares
-
Monocyte Subsets and Related Chemokines in Carotid Artery Stenosis and Ischemic Stroke
por: Grosse, Gerrit M., et al.
Publicado: (2016) -
Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection
por: Worthmann, Hans, et al.
Publicado: (2015) -
The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcome
por: Grosse, Gerrit M, et al.
Publicado: (2014) -
Circulating Inflammatory Biomarkers in Early Prediction of Stroke-Associated Infections
por: Hasse, Isabel M. C., et al.
Publicado: (2022) -
Association of dimethylarginines and mediators of inflammation after acute ischemic stroke
por: Chen, Shufen, et al.
Publicado: (2012)